{"gene":"MEOX2","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":1992,"finding":"Mox-2 (MEOX2) is a homeobox transcription factor expressed in paraxial mesoderm and its derivatives (somites, sclerotome), defining a novel homeobox gene family involved in mesodermal regionalization and somitic differentiation in mouse embryos.","method":"In situ hybridization, expression profiling in mouse embryos","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 3 — expression-based localization with developmental context, foundational characterization paper","pmids":["1363541"],"is_preprint":false},{"year":1995,"finding":"The Gax (MEOX2) homeobox gene is expressed in quiescent vascular smooth muscle cells (VSMCs) and is rapidly down-regulated in vivo following balloon angioplasty injury, mirroring the upregulation of early response genes such as c-myc and c-fos, suggesting a role in maintaining the non-proliferative VSMC phenotype.","method":"Northern blot analysis of rat carotid artery tissue after balloon injury","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct in vivo expression measurement with defined functional context","pmids":["7890661"],"is_preprint":false},{"year":1995,"finding":"The Gax (MEOX2) promoter is regulated by at least three positive transcription factors: Sp1 (binding a G/C-rich element), MEF2/RSRF (MADS box factor binding the MEF2 site, with greatest transcriptional impact in cells with highest MEF2 activity), and a third factor (HRF-1) binding an inverted palindromic motif within the 138-bp minimal promoter.","method":"Deletion analysis, transient transfection, mutagenesis, protein-DNA binding assays, MEF2A overexpression","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including mutagenesis and functional assays in a single study","pmids":["7623821"],"is_preprint":false},{"year":1996,"finding":"Protein localization of Mox-1 and Mox-2 during mouse development revealed distinct temporal onset: Mox-1 protein appears in newly formed mesoderm at 7.5 dpc, whereas Mox-2 protein is first detected at 9.0 dpc in already-formed somites, indicating distinct developmental roles despite overlapping mRNA expression patterns.","method":"Immunostaining/immunohistochemistry on mouse embryos at multiple timepoints","journal":"International Journal of Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein localization across developmental stages with functional implications","pmids":["9032023"],"is_preprint":false},{"year":1997,"finding":"Gax (MEOX2) overexpression inhibits VSMC and fibroblast proliferation through a p53-independent, p21-dependent mechanism: Gax induces p21 expression, promotes p21 association with cdk2 complexes, decreases cdk2 activity, and causes G0/G1 arrest. Fibroblasts deficient in p21 are not susceptible to Gax-mediated growth inhibition.","method":"Recombinant protein microinjection, adenoviral overexpression, p21-knockout fibroblasts, cdk2 activity assay, cell cycle analysis","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including KO cells, reconstitution, enzymatic assays, replicated in multiple cell types","pmids":["9224717"],"is_preprint":false},{"year":1997,"finding":"Gax (MEOX2) protein is expressed in the nuclei of cardiomyocytes late in chicken heart development when myocyte proliferation is declining; forced precocious nuclear Gax expression inhibits cardiomyocyte proliferation and perturbs heart morphogenesis (small ventricles, thinned compact zone), demonstrating a role as a negative regulator of cardiomyocyte proliferation.","method":"Adenoviral overexpression in chick hearts, immunohistochemistry, PCNA staining, clonal analysis","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 — direct loss-of-function/gain-of-function with specific cellular phenotype readout in vivo","pmids":["9334288"],"is_preprint":false},{"year":1997,"finding":"Angiotensin II suppresses Gax (MEOX2) mRNA expression in VSMCs via AT1 receptor signaling, while C-type natriuretic peptide (CNP) augments Gax expression through a cGMP cascade, identifying Gax as a downstream transcriptional effector of opposing vascular growth signaling pathways.","method":"RT-PCR/Northern blot in quiescent rat aortic VSMCs with pharmacological inhibitors and agonists","journal":"Hypertension","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection of signaling pathway with defined molecular readout","pmids":["9039131"],"is_preprint":false},{"year":1998,"finding":"Gax (MEOX2)-induced apoptosis requires mitogen activation and depends on Bax: forced Gax expression leads to Bcl-2 down-regulation and Bax up-regulation in mitogen-activated but not quiescent cultures, and Bax-null mouse embryonic fibroblasts are refractory to Gax-induced apoptosis. This cell death is independent of p21 and p53.","method":"Adenoviral overexpression, Bax-knockout MEFs, Western blot for Bcl-2/Bax, cell viability assays","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 1 — genetic null cells combined with overexpression and molecular readout in multiple cell types","pmids":["9649428"],"is_preprint":false},{"year":1999,"finding":"Mox2 (MEOX2) is essential for limb muscle development: Mox2 null mice show reduced limb muscle mass and loss of specific muscles, with downregulation of Pax3 and Myf5 but not MyoD in limb buds, placing MEOX2 upstream of Pax3/Myf5 in the genetic hierarchy of appendicular myogenesis.","method":"Mox2 null mouse genetic analysis, gene expression profiling, epistasis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — genetic null mouse with specific epistasis and multiple gene readouts; highly cited foundational study","pmids":["10403250"],"is_preprint":false},{"year":1999,"finding":"Gax (MEOX2) inhibits VSMC migration toward PDGF-BB, bFGF, and HGF through a p21-dependent mechanism, and specifically downregulates αvβ3 and αvβ5 integrin expression (β3 and β5 subunits) in VSMCs both in culture and after vascular injury in vivo. This effect is absent in p21-null fibroblasts but can be restored by exogenous p21 or p16.","method":"Adenoviral Gax transduction, migration assays, flow cytometry for integrin expression, p21/p53 knockout fibroblasts, in vivo vascular injury model","journal":"Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal approaches including KO cells, in vivo, and flow cytometry; mechanistic pathway established","pmids":["10562309"],"is_preprint":false},{"year":2001,"finding":"Mox1 and Mox2 (MEOX2) homeoproteins physically interact with Pax1 and Pax3 transcription factors; Mox2 shows preferential association with Pax3 over Pax1, and this interaction is mediated through the homeodomain of Mox.","method":"Yeast two-hybrid assay, in vitro biochemical pulldown assays","journal":"FEBS Letters","confidence":"Medium","confidence_rationale":"Tier 2 — yeast two-hybrid plus in vitro biochemical confirmation, domain mapping","pmids":["11423130"],"is_preprint":false},{"year":2005,"finding":"MEOX2 expression is reduced in brain endothelial cells (BECs) in Alzheimer disease; restoring MEOX2/GAX expression in AD BECs stimulates angiogenesis, transcriptionally suppresses AFX1 forkhead transcription factor-mediated apoptosis, and increases LRP1 levels at the blood-brain barrier. In mice, Meox2 deletion reduces brain capillary density, resting cerebral blood flow, angiogenic response to hypoxia, and Aβ efflux due to reduced LRP levels.","method":"Viral-mediated gene silencing and transfer in human BECs, Meox2 knockout mouse analysis, transcriptional profiling, LRP expression assays","journal":"Nature Medicine","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (gene silencing, transfer, KO mouse) with specific molecular and physiological readouts; highly cited","pmids":["16116430"],"is_preprint":false},{"year":2005,"finding":"MEOX2 binds to RING finger protein 10 (RNF10); the minimal RNF10 binding region of MEOX2 is a central region between the HQ-rich domain and the homeodomain (amino acids 101–185), and RNF10 co-expression enhances MEOX2 activation of the p21WAF1 promoter.","method":"Yeast two-hybrid screen of human heart cDNA library, in vitro pulldown, co-immunoprecipitation in mammalian cells, promoter reporter assay","journal":"Molecular and Cellular Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by co-IP and functional promoter assay","pmids":["16335786"],"is_preprint":false},{"year":2006,"finding":"Meox-2 marks early palatal mesenchymal cells and is required for maintaining adherence of palatal shelves after fusion; Meox-2 null and heterozygous mice show cleft palate resulting from post-fusion breakdown rather than failure of elevation/fusion, revealing a novel role in maintaining palatal shelf adhesion.","method":"Meox-2 knockout mouse analysis, in situ hybridization, histological analysis","journal":"Developmental Dynamics","confidence":"High","confidence_rationale":"Tier 2 — genetic null mouse with specific phenotype and mechanistic distinction from other cleft palate genes","pmids":["16284941"],"is_preprint":false},{"year":2006,"finding":"GAX (MEOX2) directly activates p21WAF1/CIP1 expression in vascular endothelial cells through multiple upstream ATTA-containing AT-rich sequences (~15 kb upstream of ATG); GAX binds these sites in a homeodomain-dependent manner, requires both the homeodomain and N-terminal domain for full transactivation, and the ability to transactivate p21 correlates with G0/G1 arrest induction.","method":"Chromatin immunoprecipitation (ChIP), domain deletion mutagenesis, luciferase reporter assays, cell cycle analysis","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — ChIP with mutagenesis and functional correlation; direct DNA binding demonstrated","pmids":["17074759"],"is_preprint":false},{"year":2007,"finding":"miR-130a directly targets two sites in the GAX (MEOX2) 3'-UTR to down-regulate GAX expression in vascular endothelial cells in response to serum and proangiogenic factors, thereby promoting the angiogenic phenotype. A 280-bp fragment from the GAX 3'-UTR is required and sufficient to mediate serum-induced down-regulation when placed in a reporter construct.","method":"3'-UTR luciferase reporter assay, forced miR-130a expression, miR-130a target site deletion analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — reporter assay with defined UTR sequences and functional miRNA expression; replicated across multiple targets","pmids":["17957028"],"is_preprint":false},{"year":2007,"finding":"Meox2 is a TGF-β/Smad pathway transcriptional target; Meox2 knockdown prevents TGF-β1-induced cytostatic response in epithelial cells, ectopic Meox2 suppresses proliferation by inducing p21 requiring a distal p53-binding site region, and Meox2 forms protein complexes with Smads to cooperatively regulate p21 gene expression. Meox2 also inhibits TGF-β-induced epithelial-mesenchymal transition.","method":"RNA interference knockdown, ectopic overexpression, co-immunoprecipitation for Smad-Meox2 complex, promoter reporter assay, cell cycle analysis","journal":"Molecular Oncology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including KD, OE, co-IP for complex formation, and promoter dissection","pmids":["19383287"],"is_preprint":false},{"year":2009,"finding":"MEOX2 (GAX) directly activates INK4a (p16) transcription by binding to the INK4a promoter as demonstrated by chromatin immunoprecipitation; MEOX2 expression increases during replicative senescence, forced MEOX2 expression induces premature senescence, and MEOX2-induced senescence is dependent on INK4a activity.","method":"Genome-scale cDNA overexpression screen, ChIP, senescence assays, INK4a-dependent epistasis","journal":"PLoS One","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP demonstrating direct promoter binding, confirmed by functional senescence dependence on INK4a","pmids":["19340300"],"is_preprint":false},{"year":2010,"finding":"ZEB2 represses GAX/MEOX2 transcription by binding to two identified ZEB2 binding sites in the GAX promoter; miR-221 upregulates GAX by downregulating ZEB2, and a mutant miR-221 fails to downregulate ZEB2 or upregulate GAX. This establishes a miR-221→ZEB2→GAX regulatory axis in vascular endothelial cells.","method":"miR-221 overexpression and inhibitor, ZEB2 identification by expression profiling, chromatin immunoprecipitation for ZEB2 binding sites, mutant miR-221 controls, promoter reporter assay","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 — ChIP defining ZEB2 binding sites, mutant controls, and functional epistasis","pmids":["20516212"],"is_preprint":false},{"year":2010,"finding":"MEOX2 protein localizes to the nuclear fraction in vascular endothelial cells; MEOX2 physically interacts with both NF-κB p65 and IκBβ by co-immunoprecipitation; MEOX2 colocalizes with p65 and IκBβ in the nucleus; this colocalization requires the MEOX2 homeodomain and N-terminal domain; MEOX2 has a biphasic effect on NF-κB-dependent promoters (stimulatory at low levels, repressive at high levels).","method":"Subcellular fractionation, co-immunoprecipitation, immunofluorescence colocalization, promoter reporter assays with domain deletion mutants","journal":"Cardiovascular Research","confidence":"High","confidence_rationale":"Tier 1–2 — co-IP confirmed by immunofluorescence, domain mapping, and functional promoter assays","pmids":["20421348"],"is_preprint":false},{"year":2011,"finding":"MEOX2 directly activates both p21CIP1/WAF1 and p16INK4a expression to induce endothelial cell cycle arrest and senescence; MEOX1 and MEOX2 activate p16INK4a in a DNA binding-dependent manner, whereas they induce p21CIP1/WAF1 in a DNA binding-independent manner, revealing mechanistically distinct modes of transcriptional activation for these two CDK inhibitor targets.","method":"Overexpression of MEOX1/MEOX2 and DNA-binding mutants, promoter reporter assays, cell cycle and senescence assays","journal":"PLoS One","confidence":"High","confidence_rationale":"Tier 1 — domain-specific DNA-binding mutants distinguishing two mechanistically distinct modes of target gene activation","pmids":["22206000"],"is_preprint":false},{"year":2011,"finding":"The miR-130/301/721 miRNA family enhances iPSC generation by targeting and repressing Meox2 (GAX); miRNA-resistant Meox2 overexpression abrogates the reprogramming effect of these miRNAs, and Meox2-specific silencing mimics their effects, demonstrating that Meox2 suppression is a key mechanism through which these miRNAs facilitate reprogramming.","method":"miRNA library screen in murine fibroblasts, miRNA-resistant Meox2 overexpression, Meox2-specific siRNA knockdown, iPSC formation assays","journal":"EMBO Reports","confidence":"High","confidence_rationale":"Tier 1–2 — epistasis established with miRNA-resistant construct and independent KD validation","pmids":["21941297"],"is_preprint":false},{"year":2013,"finding":"MEOX2 overexpression shifts cardiac myofibroblasts back toward the fibroblast phenotype, but a MEOX2 DNA-binding mutant has no effect on myofibroblast phenotype, demonstrating a DNA-binding-dependent mechanism. Ski modulates myofibroblast phenotype through suppression of Zeb2, thereby upregulating Meox2 expression (Ski→↓Zeb2→↑Meox2→fibroblast phenotype).","method":"Meox2 overexpression and DNA-binding mutant, Ski overexpression, Western blot for Zeb2, phenotypic assays, cardiac scar tissue analysis","journal":"Journal of Cell Science","confidence":"High","confidence_rationale":"Tier 2 — DNA-binding mutant establishes mechanism, supported by pathway epistasis with Ski/Zeb2","pmids":["24155330"],"is_preprint":false},{"year":2015,"finding":"Meox2/Tcf15 form heterodimers that function as transcriptional determinants of heart capillary endothelial cell identity; Meox2/Tcf15 drive endothelial CD36 and lipoprotein lipase expression to mediate fatty acid uptake in heart ECs and facilitate FA transport to cardiomyocytes. Combined Meox2/Tcf15 haplodeficiency impairs cardiac FA uptake and contractility.","method":"Microarray profiling of freshly isolated ECs, gain- and loss-of-function genetic approaches, combined haplodeficiency mouse model, cardiac contractility measurement","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches including heterodimerization, gain/loss-of-function, and in vivo physiological readout","pmids":["25561514"],"is_preprint":false},{"year":2016,"finding":"Meox2 haploinsufficiency in a mouse model of Alzheimer's disease increases neuronal cell loss in regions containing plaques and decreases plaque-associated microvessel density, supporting a synergistic effect of vascular compromise and amyloid deposition on neuronal dysfunction.","method":"Meox2 haploinsufficiency combined with APP/PS1 transgenic mouse model, histological analysis, microvessel quantification","journal":"Neurobiology of Aging","confidence":"Medium","confidence_rationale":"Tier 2 — genetic interaction in defined mouse model with specific cellular phenotype readout","pmids":["27143421"],"is_preprint":false},{"year":2022,"finding":"MEOX2 enhances ERK signaling in glioblastoma through a feed-forward mechanism; Ser155 is a putative ERK-dependent phosphorylation site upstream of the homeodomain, and S155A substitution affects MEOX2 protein levels and alters its subnuclear localization. MEOX2 overexpression cooperates with p53 and PTEN loss to induce cell proliferation in cerebral organoid models.","method":"Constitutive knockdown/overexpression in patient-derived GBM tumorspheres, ERK phosphorylation assays by Western blot, S155A mutagenesis, cerebral organoid models, RNA-seq, ACT-seq, CUT&Tag for target gene identification","journal":"Neuro-oncology","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis of phosphorylation site, multiple genomics approaches, and in vivo organoid model","pmids":["35468210"],"is_preprint":false},{"year":2022,"finding":"MEOX2 directly activates Cathepsin S (CTSS) transcription in glioma cells as demonstrated by ChIP-qPCR and luciferase reporter assay; MEOX2 promotes glioma cell proliferation, motility, EMT, focal adhesion formation, and F-actin assembly, partly through CTSS regulation.","method":"RNA-sequencing, ChIP-qPCR, luciferase reporter assay, MEOX2 knockdown/overexpression, in vivo mouse intracranial implantation model","journal":"Cell Death & Disease","confidence":"High","confidence_rationale":"Tier 1 — ChIP-qPCR combined with reporter assay and in vivo validation identifies direct transcriptional target","pmids":["35436995"],"is_preprint":false},{"year":2022,"finding":"ABI2 directly interacts with MEOX2 by co-immunoprecipitation; MEOX2 binds to KLF4 and NANOG promoter regions to activate their transcription, maintaining cancer stem cell populations in HCC; MEOX2 overexpression restores ABI2 knockdown effects on malignant behavior.","method":"Co-immunoprecipitation, ChIP for MEOX2 binding to KLF4/NANOG promoters, functional rescue experiments, xenograft models","journal":"Liver International","confidence":"High","confidence_rationale":"Tier 1–2 — co-IP for protein interaction plus ChIP defining direct promoter binding and functional rescue","pmids":["36017822"],"is_preprint":false},{"year":2022,"finding":"MEOX2 is involved in cell viability, proliferation, and adhesion of glioma stem-like cells through ERK/MAPK and PI3K/AKT pathways; MEOX2 loss of function correlates with GSC differentiation toward neuronal lineage characteristics and decreased pFAK with increased CDH10 expression.","method":"siRNA loss-of-function in GSCs, cell viability assays, Western blot for pathway components, differentiation assays","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, single KD approach with pathway readouts but no direct binding or mutagenesis","pmids":["34885053"],"is_preprint":false},{"year":2022,"finding":"MEOX2 regulates genes of the glycolytic pathway and hypoxic response in glioblastoma stem-like cells; shRNA-mediated MEOX2 knockdown inhibits cell growth, sphere-forming ability, and increases apoptosis; in silico analysis identifies GC-rich Sp1 and Klf4 binding motifs in regulatory regions of MEOX2-regulated genes.","method":"shRNA knockdown in GSC lines, transcriptome analysis (RNA-seq), sphere-forming assay, apoptosis assay","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 — transcriptome analysis with functional validation in multiple GSC lines","pmids":["35565433"],"is_preprint":false},{"year":2022,"finding":"MEOX2 and GLI1 epigenetically regulate EGFR gene expression in lung cancer by reducing repressive histone marks (EZH2/H3K27me3) and increasing activating marks (H3K27Ac/H3K4me3) at the EGFR gene enhancer-promoter sequences, contributing to EGFR-TKI resistance.","method":"shRNA silencing, ChIP-qPCR for histone modifications at EGFR locus, Western blot, in vivo tumor progression models","journal":"European Journal of Cancer","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-qPCR demonstrating epigenetic mechanism at specific genomic loci","pmids":["34844838"],"is_preprint":false},{"year":2022,"finding":"MEOX2 modulates nociceptor function: MEOX2 is expressed in mouse dorsal root ganglia sensory neuron nuclei, and Meox2 heterozygosity impairs action potential initiation, correlating with decreased expression of Scn9a (Nav1.7) and Scn11a (Nav1.9) voltage-gated sodium channels. Transcriptomic analysis reveals downregulation of pain perception genes (PENK, NPY) in Meox2+/- DRG.","method":"Meox2 heterozygous mouse model, behavioral analysis, electrophysiology, immunofluorescence, transcriptomic analysis, qPCR","journal":"FEBS Journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (behavior, electrophysiology, transcriptomics) in genetic model with identified downstream targets","pmids":["35029322"],"is_preprint":false},{"year":2023,"finding":"RNF10 interacts with Meox2 and MEOX2 overexpression promotes Meox2 expression while inhibiting AP-1 in cardiomyocytes; overexpression of RNF10 in H9C2 cells significantly promotes Meox2, inhibits AP-1, alleviates apoptosis, and antagonizes pirarubicin-induced cardiotoxicity, demonstrating the AP-1/Meox2 signaling axis downstream of RNF10.","method":"siRNA and lentiviral overexpression of RNF10 in H9C2 cells, Western blot for Meox2 and AP-1, apoptosis assays, in vivo rat cardiotoxicity model","journal":"Oxidative Medicine and Cellular Longevity","confidence":"Medium","confidence_rationale":"Tier 2 — bidirectional manipulation (KD and OE) with pathway readouts confirmed in vivo","pmids":["36713029"],"is_preprint":false},{"year":2024,"finding":"MEOX2 binds to the PHLPP promoter to upregulate its transcription (demonstrated by dual luciferase reporter assay), leading to inhibition of p-AKT expression and reduced HSC proliferation; MEOX2 overexpression inhibits hepatic stellate cell vitality and proliferation through the PHLPP/PI3K/AKT axis.","method":"Lentiviral OE and shRNA KD of MEOX2, dual luciferase reporter assay for MEOX2 binding to PHLPP promoter, Western blot for p-AKT, CCK-8 and EdU proliferation assays","journal":"Discovery Medicine","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding established by reporter assay with functional downstream pathway validation","pmids":["38926106"],"is_preprint":false},{"year":2025,"finding":"NAT10-mediated ac4C RNA modification at nucleotides 409–423 of MEOX2 mRNA regulates MEOX2 mRNA stability and expression; NAT10 directly binds MEOX2 mRNA (demonstrated by RIP), and NAT10 silencing reduces ac4C modification and MEOX2 expression, promoting HUVEC migration, invasion, and angiogenesis. MEOX2 overexpression reverses the effects of NAT10 inhibition.","method":"MeRIP-qPCR, RNA immunoprecipitation, dual-luciferase reporter assay, RNA stability assay, functional cellular assays in HUVECs","journal":"Applied Biochemistry and Biotechnology","confidence":"Medium","confidence_rationale":"Tier 2 — direct RNA modification mapping by MeRIP-qPCR with RIP confirmation and functional rescue","pmids":["41082000"],"is_preprint":false},{"year":2025,"finding":"MEOX2 interacts with PARP1 (identified by co-immunoprecipitation and mass spectrometry) in glioblastoma stem-like cells; MEOX2 depletion reduces PARylation levels, impairs DNA repair, and increases sensitivity to the PARP1 inhibitor Talazoparib. MEOX2 knockdown impairs tumor growth and increases temozolomide sensitivity in a GLICO (cerebral organoid) model.","method":"Co-immunoprecipitation, mass spectrometry, PARylation assays, PARP inhibitor sensitivity, GLICO tumor organoid model, DNA damage assays","journal":"Cancer Letters","confidence":"High","confidence_rationale":"Tier 1–2 — co-IP with mass spectrometry identifying interactor, functional validation with inhibitor sensitivity and organoid model","pmids":["41620199"],"is_preprint":false}],"current_model":"MEOX2/GAX is a homeodomain transcription factor that acts primarily as a negative regulator of cell proliferation and angiogenesis: it directly binds ATTA-containing upstream sequences to transcriptionally activate p21CIP1/WAF1 (DNA binding-independent in some contexts), activates p16INK4a (DNA binding-dependent), represses NF-κB activity through direct interaction with p65 and IκBβ, forms heterodimers with Tcf15 to drive heart capillary EC identity and fatty acid uptake, physically interacts with Pax3, Smads, RNF10, and PARP1 to modulate diverse cellular processes, is regulated post-transcriptionally by multiple miRNAs (miR-130a, miR-221/ZEB2 axis) targeting its 3'-UTR, is phosphorylated at Ser155 by ERK (affecting its stability and subnuclear localization), and plays essential developmental roles in limb myogenesis, somitogenesis, palatogenesis, and nociceptor maintenance by controlling downstream transcriptional programs including Pax3, Myf5, Nav1.7, and Nav1.9."},"narrative":{"teleology":[{"year":1992,"claim":"Identifying MEOX2 as a novel homeobox gene expressed in paraxial mesoderm and somites established it as a transcription factor with potential roles in mesodermal patterning, prior to any knowledge of its targets or function.","evidence":"In situ hybridization expression profiling in mouse embryos","pmids":["1363541"],"confidence":"Medium","gaps":["No functional data; expression pattern alone","No downstream targets identified","No loss-of-function data"]},{"year":1995,"claim":"Demonstrating that MEOX2/GAX is highly expressed in quiescent VSMCs and rapidly downregulated upon vascular injury linked it to growth-arrest maintenance, while promoter analysis identified Sp1, MEF2, and HRF-1 as upstream regulators of MEOX2 transcription.","evidence":"Northern blot of injured rat carotid arteries; deletion/mutagenesis analysis of the Gax promoter with transient transfection and protein-DNA binding assays","pmids":["7890661","7623821"],"confidence":"Medium","gaps":["No direct demonstration that MEOX2 loss causes VSMC proliferation","Mechanism of growth arrest unknown"]},{"year":1997,"claim":"Establishing that MEOX2 inhibits proliferation via p21-dependent CDK2 inactivation and induces G0/G1 arrest—confirmed by resistance of p21-null cells—provided the first mechanistic link between MEOX2 and cell cycle control, while parallel work showed it also inhibits cardiomyocyte proliferation in vivo.","evidence":"Adenoviral overexpression, microinjection, p21-knockout fibroblasts, cdk2 activity assays; forced expression in chick hearts with PCNA staining","pmids":["9224717","9334288"],"confidence":"High","gaps":["Whether MEOX2 directly binds p21 promoter unknown","Mechanism in cardiomyocytes could differ from VSMCs"]},{"year":1998,"claim":"Showing that MEOX2 induces apoptosis in mitogen-activated cells through Bax upregulation and Bcl-2 downregulation—independent of p21 and p53—revealed a second, distinct anti-proliferative output beyond cell cycle arrest.","evidence":"Adenoviral overexpression in Bax-knockout MEFs with Bcl-2/Bax Western blots and viability assays","pmids":["9649428"],"confidence":"High","gaps":["Whether MEOX2 directly regulates Bax transcription or acts indirectly unknown","Apoptotic pathway not confirmed in vascular cells in vivo"]},{"year":1999,"claim":"Genetic ablation of Meox2 in mice revealed its essential role in limb myogenesis—acting upstream of Pax3 and Myf5—establishing MEOX2 as a master regulator of appendicular muscle development, while complementary work showed MEOX2 inhibits VSMC migration through p21-dependent integrin downregulation.","evidence":"Meox2-null mouse analysis with epistasis; adenoviral Gax transduction with migration assays, flow cytometry, and p21-KO fibroblasts","pmids":["10403250","10562309"],"confidence":"High","gaps":["Direct transcriptional regulation of Pax3 by MEOX2 not demonstrated","Whether integrin regulation is transcriptionally direct unknown"]},{"year":2001,"claim":"Identifying physical interaction between the MEOX2 homeodomain and Pax3 provided a molecular basis for the genetic epistasis observed in limb myogenesis.","evidence":"Yeast two-hybrid and in vitro pulldown assays with domain mapping","pmids":["11423130"],"confidence":"Medium","gaps":["Functional consequence of MEOX2-Pax3 interaction on target gene regulation not tested","No in vivo confirmation of the complex"]},{"year":2005,"claim":"Two key advances expanded MEOX2's role: (1) demonstration that MEOX2 loss in Alzheimer's brain endothelium reduces LRP1 and cerebrovascular function, and (2) identification of RNF10 as a physical interactor that enhances MEOX2-dependent p21 promoter activation.","evidence":"Gene transfer/silencing in human brain ECs and Meox2-KO mouse cerebrovascular analysis; yeast two-hybrid confirmed by co-IP with p21 reporter assay","pmids":["16116430","16335786"],"confidence":"High","gaps":["Whether MEOX2 directly regulates LRP1 transcription not resolved","RNF10-MEOX2 interaction not tested for ubiquitination function"]},{"year":2006,"claim":"ChIP demonstrated that MEOX2 directly binds multiple ATTA-containing sites ~15 kb upstream of p21, requiring both the homeodomain and N-terminal domain, while knockout analysis revealed an unexpected role in palatal shelf maintenance after fusion.","evidence":"ChIP, domain deletion mutagenesis, reporter assays in endothelial cells; Meox2-null mouse histological analysis of palate","pmids":["17074759","16284941"],"confidence":"High","gaps":["Whether the same distal elements are used in all cell types unknown","Palatal phenotype mechanism not molecularly defined"]},{"year":2007,"claim":"miR-130a was identified as a direct negative regulator of MEOX2 via its 3′-UTR, establishing the first post-transcriptional control mechanism and explaining serum-induced MEOX2 downregulation during angiogenesis; simultaneously, MEOX2 was placed as a TGF-β/Smad transcriptional target that cooperates with Smads to activate p21.","evidence":"3′-UTR reporter assays with miR-130a target site deletion; RNAi, co-IP for Smad-MEOX2 complex, and p21 promoter dissection","pmids":["17957028","19383287"],"confidence":"High","gaps":["Whether Smad-MEOX2 complex binds DNA cooperatively at specific sites not shown by ChIP","Other miRNAs targeting MEOX2 3′-UTR not systematically explored at this point"]},{"year":2010,"claim":"Two studies clarified MEOX2's interactions with inflammation and upstream transcriptional control: MEOX2 physically associates with NF-κB p65 and IκBβ in the nucleus to modulate NF-κB activity, and ZEB2 directly represses MEOX2 transcription through defined promoter sites, with miR-221 relieving this repression.","evidence":"Co-IP, immunofluorescence, domain deletion, NF-κB reporter assays; ChIP for ZEB2 binding, mutant miR-221 controls","pmids":["20421348","20516212"],"confidence":"High","gaps":["In vivo relevance of NF-κB modulation by MEOX2 not tested","Whether ZEB2 repression operates in non-endothelial contexts unknown"]},{"year":2011,"claim":"Demonstrating that MEOX2 activates p16INK4a in a DNA binding-dependent manner but p21 in a DNA binding-independent manner resolved how a single transcription factor uses mechanistically distinct modes to engage two CDK inhibitor targets; suppression of MEOX2 by miR-130/301 family was shown to facilitate iPSC reprogramming.","evidence":"DNA-binding mutant overexpression with promoter reporters and senescence assays; miRNA-resistant MEOX2 construct and siRNA epistasis in iPSC assays","pmids":["22206000","21941297"],"confidence":"High","gaps":["Cofactors mediating DNA binding-independent p21 activation unidentified","Mechanism by which MEOX2 blocks reprogramming beyond proliferation arrest not defined"]},{"year":2015,"claim":"Identification of Meox2/Tcf15 heterodimers as transcriptional determinants of heart capillary endothelial identity—driving CD36 and lipoprotein lipase for fatty acid uptake—revealed a metabolic function distinct from MEOX2's anti-proliferative roles.","evidence":"Microarray of freshly isolated ECs, genetic gain/loss-of-function, combined haplodeficiency mouse with cardiac contractility measurements","pmids":["25561514"],"confidence":"High","gaps":["Direct DNA-binding sites for Meox2/Tcf15 heterodimer not mapped","Whether this metabolic program operates in non-cardiac endothelium unknown"]},{"year":2022,"claim":"Multiple studies revealed MEOX2 as an oncogenic transcription factor in glioblastoma—enhancing ERK signaling via Ser155 phosphorylation, directly activating Cathepsin S transcription, and regulating glycolytic/hypoxic gene programs—while also establishing its role in nociceptor function through control of Nav1.7/Nav1.9 expression.","evidence":"S155A mutagenesis and cerebral organoid models; ChIP-qPCR for CTSS; shRNA with RNA-seq in GSCs; Meox2-heterozygous mice with electrophysiology and transcriptomics","pmids":["35468210","35436995","35565433","35029322"],"confidence":"High","gaps":["Whether Ser155 phosphorylation is the sole post-translational modification governing MEOX2 stability","Direct vs indirect regulation of sodium channel genes not resolved","Context-dependent switch between tumor-suppressive and oncogenic roles not mechanistically explained"]},{"year":2025,"claim":"MEOX2 mRNA was shown to be stabilized by NAT10-mediated ac4C modification, adding an epitranscriptomic layer of regulation, while identification of PARP1 as a MEOX2 interactor linked MEOX2 to DNA repair and PARP inhibitor sensitivity in glioblastoma.","evidence":"MeRIP-qPCR and RIP for ac4C modification in HUVECs; co-IP with mass spectrometry, PARylation assays, and PARP inhibitor sensitivity in GLICO organoid models","pmids":["41082000","41620199"],"confidence":"High","gaps":["Whether ac4C modification is regulated in vivo during angiogenesis not tested","Structural basis of MEOX2-PARP1 interaction unknown","Whether MEOX2 stimulates PARP1 catalytic activity or serves as scaffold not distinguished"]},{"year":null,"claim":"Key unresolved questions include the structural basis for MEOX2's DNA binding-independent activation of p21, the molecular determinants that switch MEOX2 between tumor-suppressive and oncogenic roles across tissue contexts, and whether MEOX2's metabolic functions in cardiac endothelium extend to other vascular beds.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of MEOX2 or its complexes available","Context-dependent transcriptional programs not systematically compared across tissues","In vivo relevance of many protein-protein interactions (Smads, PARP1, ABI2) not confirmed by genetic epistasis"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[14,17,20,26,27]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[4,14,16,17,20,23,26,27,33]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,19,31]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[4,9,14,17,20]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[7,11]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,16,19,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,3,8,13]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[14,17,20,26,27,33]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[35]}],"complexes":["Meox2/Tcf15 heterodimer","MEOX2/NF-κB p65/IκBβ complex","MEOX2/Smad complex"],"partners":["TCF15","PAX3","RNF10","RELA","NFKBIB","PARP1","ABI2"],"other_free_text":[]},"mechanistic_narrative":"MEOX2 (also known as GAX) is a homeodomain transcription factor that functions as a context-dependent regulator of cell proliferation, vascular homeostasis, and tissue-specific differentiation during development and in adult tissues. MEOX2 directly binds ATTA-containing promoter elements to transcriptionally activate the cyclin-dependent kinase inhibitors p21CIP1/WAF1 (via distal upstream sites) and p16INK4a, inducing cell cycle arrest and senescence in vascular smooth muscle cells and endothelial cells through mechanistically distinct DNA binding-dependent (p16) and DNA binding-independent (p21) modes [PMID:9224717, PMID:22206000, PMID:17074759, PMID:19340300]. In development, MEOX2 is essential for limb myogenesis—acting upstream of Pax3 and Myf5—palatal shelf maintenance, and nociceptor function through regulation of Nav1.7/Nav1.9 sodium channels, while in cardiac endothelium it heterodimerizes with Tcf15 to drive fatty acid transporter expression and cardiac metabolic support [PMID:10403250, PMID:16284941, PMID:35029322, PMID:25561514]. MEOX2 is itself regulated post-transcriptionally by miR-130a targeting its 3′-UTR, transcriptionally by ZEB2 repression relieved via miR-221, and post-translationally by ERK-mediated Ser155 phosphorylation affecting its stability and subnuclear distribution; it physically interacts with NF-κB p65/IκBβ to modulate inflammatory signaling, with Smads to mediate TGF-β cytostatic responses, and with PARP1 to support DNA repair in glioblastoma stem cells [PMID:17957028, PMID:20516212, PMID:35468210, PMID:20421348, PMID:19383287, PMID:41620199]."},"prefetch_data":{"uniprot":{"accession":"P50222","full_name":"Homeobox protein MOX-2","aliases":["Growth arrest-specific homeobox","Mesenchyme homeobox 2"],"length_aa":304,"mass_kda":33.6,"function":"Mesodermal transcription factor that plays a key role in somitogenesis and somitogenesis and limb muscle differentiation (By similarity). Required during limb development for normal appendicular muscle formation and for the normal regulation of myogenic genes (By similarity). May have a regulatory role when quiescent vascular smooth muscle cells reenter the cell cycle (By similarity). Also acts as a negative regulator of angiogenesis (PubMed:17074759, PubMed:20516212, PubMed:22206000). Activates expression of CDKN1A and CDKN2A in endothelial cells, acting as a regulator of vascular cell proliferation (PubMed:17074759, PubMed:22206000). While it activates CDKN1A in a DNA-dependent manner, it activates CDKN2A in a DNA-independent manner (PubMed:22206000). Together with TCF15, regulates transcription in heart endothelial cells to regulate fatty acid transport across heart endothelial cells (By similarity)","subcellular_location":"Nucleus; Nucleus speckle","url":"https://www.uniprot.org/uniprotkb/P50222/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MEOX2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MEOX2","total_profiled":1310},"omim":[{"mim_id":"615998","title":"RING FINGER PROTEIN 10; RNF10","url":"https://www.omim.org/entry/615998"},{"mim_id":"615675","title":"MICRO RNA 301A; MIR301A","url":"https://www.omim.org/entry/615675"},{"mim_id":"610175","title":"MICRO RNA 130A; MIR130A","url":"https://www.omim.org/entry/610175"},{"mim_id":"600535","title":"MESENCHYME HOMEOBOX 2; MEOX2","url":"https://www.omim.org/entry/600535"},{"mim_id":"600147","title":"MESENCHYME HOMEOBOX 1; MEOX1","url":"https://www.omim.org/entry/600147"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":38.4},{"tissue":"blood vessel","ntpm":30.8},{"tissue":"placenta","ntpm":39.6}],"url":"https://www.proteinatlas.org/search/MEOX2"},"hgnc":{"alias_symbol":["MOX2"],"prev_symbol":["GAX"]},"alphafold":{"accession":"P50222","domains":[{"cath_id":"1.10.10.60","chopping":"197-262","consensus_level":"high","plddt":86.8565,"start":197,"end":262}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P50222","model_url":"https://alphafold.ebi.ac.uk/files/AF-P50222-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P50222-F1-predicted_aligned_error_v6.png","plddt_mean":60.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MEOX2","jax_strain_url":"https://www.jax.org/strain/search?query=MEOX2"},"sequence":{"accession":"P50222","fasta_url":"https://rest.uniprot.org/uniprotkb/P50222.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P50222/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P50222"}},"corpus_meta":[{"pmid":"17957028","id":"PMC_17957028","title":"Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17957028","citation_count":386,"is_preprint":false},{"pmid":"1363541","id":"PMC_1363541","title":"Mox-1 and Mox-2 define a novel homeobox gene subfamily and are differentially expressed during early mesodermal patterning in mouse embryos.","date":"1992","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1363541","citation_count":263,"is_preprint":false},{"pmid":"16116430","id":"PMC_16116430","title":"Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease.","date":"2005","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16116430","citation_count":243,"is_preprint":false},{"pmid":"9224717","id":"PMC_9224717","title":"p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene.","date":"1997","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9224717","citation_count":155,"is_preprint":false},{"pmid":"10403250","id":"PMC_10403250","title":"Mox2 is a component of the genetic hierarchy controlling limb muscle development.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10403250","citation_count":150,"is_preprint":false},{"pmid":"7890661","id":"PMC_7890661","title":"Expression of gax, a growth arrest homeobox gene, is rapidly down-regulated in the rat carotid artery during the proliferative response to balloon injury.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7890661","citation_count":85,"is_preprint":false},{"pmid":"25561514","id":"PMC_25561514","title":"Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake.","date":"2015","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/25561514","citation_count":84,"is_preprint":false},{"pmid":"20470754","id":"PMC_20470754","title":"Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/CREB pathways.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20470754","citation_count":80,"is_preprint":false},{"pmid":"21941297","id":"PMC_21941297","title":"miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2.","date":"2011","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/21941297","citation_count":75,"is_preprint":false},{"pmid":"20516212","id":"PMC_20516212","title":"Regulation of the expression and activity of the antiangiogenic homeobox gene GAX/MEOX2 by ZEB2 and microRNA-221.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20516212","citation_count":74,"is_preprint":false},{"pmid":"10562309","id":"PMC_10562309","title":"Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor.","date":"1999","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10562309","citation_count":69,"is_preprint":false},{"pmid":"22373864","id":"PMC_22373864","title":"miR-301a is a candidate oncogene that targets the homeobox gene Gax in human hepatocellular carcinoma.","date":"2012","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22373864","citation_count":64,"is_preprint":false},{"pmid":"12842453","id":"PMC_12842453","title":"Inhibition of endothelial cell activation by the homeobox gene Gax.","date":"2003","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/12842453","citation_count":62,"is_preprint":false},{"pmid":"22206000","id":"PMC_22206000","title":"Mechanisms of MEOX1 and MEOX2 regulation of the cyclin dependent kinase inhibitors p21 and p16 in vascular endothelial cells.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22206000","citation_count":58,"is_preprint":false},{"pmid":"9415299","id":"PMC_9415299","title":"Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty.","date":"1997","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/9415299","citation_count":57,"is_preprint":false},{"pmid":"33627047","id":"PMC_33627047","title":"Tumor-derived exosomal miRNA-141 promote angiogenesis and malignant progression of lung cancer by targeting growth arrest-specific homeobox gene (GAX).","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/33627047","citation_count":48,"is_preprint":false},{"pmid":"9649428","id":"PMC_9649428","title":"Bax-mediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9649428","citation_count":46,"is_preprint":false},{"pmid":"32582277","id":"PMC_32582277","title":"MiR-148a-3p Regulates Skeletal Muscle Satellite Cell Differentiation and Apoptosis via the PI3K/AKT Signaling Pathway by Targeting Meox2.","date":"2020","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32582277","citation_count":45,"is_preprint":false},{"pmid":"24155330","id":"PMC_24155330","title":"The Ski-Zeb2-Meox2 pathway provides a novel mechanism for regulation of the cardiac myofibroblast phenotype.","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24155330","citation_count":40,"is_preprint":false},{"pmid":"9032023","id":"PMC_9032023","title":"Differential localization of Mox-1 and Mox-2 proteins indicates distinct roles during development.","date":"1996","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9032023","citation_count":40,"is_preprint":false},{"pmid":"16284941","id":"PMC_16284941","title":"Analysis of Meox-2 mutant mice reveals a novel postfusion-based cleft palate.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16284941","citation_count":40,"is_preprint":false},{"pmid":"10505098","id":"PMC_10505098","title":"Adenovirus-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle proliferation and induces apoptosis.","date":"1999","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/10505098","citation_count":39,"is_preprint":false},{"pmid":"10981661","id":"PMC_10981661","title":"Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries.","date":"2000","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/10981661","citation_count":38,"is_preprint":false},{"pmid":"7623821","id":"PMC_7623821","title":"Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7623821","citation_count":36,"is_preprint":false},{"pmid":"11423130","id":"PMC_11423130","title":"Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11423130","citation_count":34,"is_preprint":false},{"pmid":"10831122","id":"PMC_10831122","title":"The homeobox genes MSX2 and MOX2 are candidates for regulating epithelial-mesenchymal cell interactions in the human placenta.","date":"2000","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/10831122","citation_count":34,"is_preprint":false},{"pmid":"17939123","id":"PMC_17939123","title":"A comparative analysis of Meox1 and Meox2 in the developing somites and limbs of the chick embryo.","date":"2007","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17939123","citation_count":34,"is_preprint":false},{"pmid":"17074759","id":"PMC_17074759","title":"The homeobox gene GAX activates p21WAF1/CIP1 expression in vascular endothelial cells through direct interaction with upstream AT-rich sequences.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17074759","citation_count":33,"is_preprint":false},{"pmid":"36017822","id":"PMC_36017822","title":"ABI2-mediated MEOX2/KLF4-NANOG axis promotes liver cancer stem cell and drives tumour recurrence.","date":"2022","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/36017822","citation_count":32,"is_preprint":false},{"pmid":"18187669","id":"PMC_18187669","title":"Cross talk among Smad, MAPK, and integrin signaling pathways enhances adventitial fibroblast functions activated by transforming growth factor-beta1 and inhibited by Gax.","date":"2008","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18187669","citation_count":32,"is_preprint":false},{"pmid":"9118475","id":"PMC_9118475","title":"Embryonic expression of the Gax homeodomain protein in cardiac, smooth, and skeletal muscle.","date":"1997","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/9118475","citation_count":32,"is_preprint":false},{"pmid":"9039131","id":"PMC_9039131","title":"Opposite regulation of Gax homeobox expression by angiotensin II and C-type natriuretic peptide.","date":"1997","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/9039131","citation_count":31,"is_preprint":false},{"pmid":"19760604","id":"PMC_19760604","title":"Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor.","date":"2009","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19760604","citation_count":30,"is_preprint":false},{"pmid":"19383287","id":"PMC_19383287","title":"Functional role of Meox2 during the epithelial cytostatic response to TGF-beta.","date":"2007","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19383287","citation_count":28,"is_preprint":false},{"pmid":"20160044","id":"PMC_20160044","title":"Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.","date":"2010","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20160044","citation_count":27,"is_preprint":false},{"pmid":"34516311","id":"PMC_34516311","title":"Exosomal circular RNA circ_0074673 regulates the proliferation, migration, and angiogenesis of human umbilical vein endothelial cells via the microRNA-1200/MEOX2 axis.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34516311","citation_count":26,"is_preprint":false},{"pmid":"20421348","id":"PMC_20421348","title":"MEOX2 regulates nuclear factor-kappaB activity in vascular endothelial cells through interactions with p65 and IkappaBbeta.","date":"2010","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/20421348","citation_count":26,"is_preprint":false},{"pmid":"27143421","id":"PMC_27143421","title":"Meox2 haploinsufficiency increases neuronal cell loss in a mouse model of Alzheimer's disease.","date":"2016","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/27143421","citation_count":26,"is_preprint":false},{"pmid":"28326537","id":"PMC_28326537","title":"Gax suppresses chemerin/CMKLR1-induced preadipocyte biofunctions through the inhibition of Akt/mTOR and ERK signaling pathways.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28326537","citation_count":26,"is_preprint":false},{"pmid":"35468210","id":"PMC_35468210","title":"MEOX2 homeobox gene promotes growth of malignant gliomas.","date":"2022","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35468210","citation_count":26,"is_preprint":false},{"pmid":"25239227","id":"PMC_25239227","title":"Involvement of IGF-1 and MEOX2 in PI3K/Akt1/2 and ERK1/2 pathways mediated proliferation and differentiation of perivascular adipocytes.","date":"2014","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/25239227","citation_count":26,"is_preprint":false},{"pmid":"19340300","id":"PMC_19340300","title":"A functional screen for regulators of CKDN2A reveals MEOX2 as a transcriptional activator of INK4a.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19340300","citation_count":25,"is_preprint":false},{"pmid":"9334288","id":"PMC_9334288","title":"Forced expression of the homeodomain protein Gax inhibits cardiomyocyte proliferation and perturbs heart morphogenesis.","date":"1997","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9334288","citation_count":25,"is_preprint":false},{"pmid":"7577672","id":"PMC_7577672","title":"The expression pattern of Xenopus Mox-2 implies a role in initial mesodermal differentiation.","date":"1995","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/7577672","citation_count":24,"is_preprint":false},{"pmid":"29940775","id":"PMC_29940775","title":"Over-expression of MEOX2 promotes apoptosis through inhibiting the PI3K/Akt pathway in laryngeal cancer cells.","date":"2018","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/29940775","citation_count":22,"is_preprint":false},{"pmid":"16335786","id":"PMC_16335786","title":"Characterization of Mesenchyme Homeobox 2 (MEOX2) transcription factor binding to RING finger protein 10.","date":"2005","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16335786","citation_count":22,"is_preprint":false},{"pmid":"24587088","id":"PMC_24587088","title":"Regulatory specialization of xyloglucan (XG) and glucuronoarabinoxylan (GAX) in pericarp cell walls during fruit ripening in tomato (Solanum lycopersicum).","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24587088","citation_count":21,"is_preprint":false},{"pmid":"7607679","id":"PMC_7607679","title":"Isolation of the human MOX2 homeobox gene and localization to chromosome 7p22.1-p21.3.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7607679","citation_count":18,"is_preprint":false},{"pmid":"35436995","id":"PMC_35436995","title":"MEOX2-mediated regulation of Cathepsin S promotes cell proliferation and motility in glioma.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35436995","citation_count":17,"is_preprint":false},{"pmid":"7713505","id":"PMC_7713505","title":"Molecular cloning and localization of the human GAX gene to 7p21.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7713505","citation_count":17,"is_preprint":false},{"pmid":"20598309","id":"PMC_20598309","title":"Gax gene transfer inhibits vascular remodeling induced by adventitial inflammation in rabbits.","date":"2010","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/20598309","citation_count":17,"is_preprint":false},{"pmid":"28514291","id":"PMC_28514291","title":"Role of microRNA-130a in the pathogeneses of obstructive sleep apnea hypopnea syndrome-associated pulmonary hypertension by targeting the GAX gene.","date":"2017","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28514291","citation_count":16,"is_preprint":false},{"pmid":"9457671","id":"PMC_9457671","title":"Characterization and localization of Mox2, the gene encoding the murine homolog of the rat MRC OX-2 membrane glycoprotein.","date":"1998","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/9457671","citation_count":14,"is_preprint":false},{"pmid":"34844838","id":"PMC_34844838","title":"Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer.","date":"2021","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/34844838","citation_count":14,"is_preprint":false},{"pmid":"34306209","id":"PMC_34306209","title":"MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34306209","citation_count":14,"is_preprint":false},{"pmid":"15680482","id":"PMC_15680482","title":"Angiotensin II suppresses growth arrest specific homeobox (Gax) expression via redox-sensitive mitogen-activated protein kinase (MAPK).","date":"2005","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/15680482","citation_count":12,"is_preprint":false},{"pmid":"27508012","id":"PMC_27508012","title":"Gax regulates human vascular smooth muscle cell phenotypic modulation and vascular remodeling.","date":"2016","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/27508012","citation_count":11,"is_preprint":false},{"pmid":"8893412","id":"PMC_8893412","title":"Growth-arrest homeobox gene Gax: a molecular strategy to prevent arterial restenosis.","date":"1996","source":"Schweizerische medizinische Wochenschrift","url":"https://pubmed.ncbi.nlm.nih.gov/8893412","citation_count":11,"is_preprint":false},{"pmid":"33218046","id":"PMC_33218046","title":"Facilitation of Bone Healing Processes Based on the Developmental Function of Meox2 in Tooth Loss Lesion.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33218046","citation_count":11,"is_preprint":false},{"pmid":"34885053","id":"PMC_34885053","title":"MEOX2 Transcription Factor Is Involved in Survival and Adhesion of Glioma Stem-like Cells.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34885053","citation_count":9,"is_preprint":false},{"pmid":"25445500","id":"PMC_25445500","title":"Ski diminishes TGF-β1-induced myofibroblast phenotype via up-regulating Meox2 expression.","date":"2014","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25445500","citation_count":9,"is_preprint":false},{"pmid":"34224325","id":"PMC_34224325","title":"The promotion of cervical cancer progression by signal transducer and activator of transcription 1-induced up-regulation of lncRNA MEOX2-AS1 as a competing endogenous RNA through miR-143-3p/VDAC1 pathway.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34224325","citation_count":9,"is_preprint":false},{"pmid":"34160343","id":"PMC_34160343","title":"MEOX2 serves as a novel biomarker associated with macrophage infiltration in oesophageal squamous cell carcinoma and other digestive system carcinomas.","date":"2021","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/34160343","citation_count":7,"is_preprint":false},{"pmid":"35565433","id":"PMC_35565433","title":"MEOX2 Regulates the Growth and Survival of Glioblastoma Stem Cells by Modulating Genes of the Glycolytic Pathway and Response to Hypoxia.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35565433","citation_count":7,"is_preprint":false},{"pmid":"35029322","id":"PMC_35029322","title":"Transcription factor mesenchyme homeobox protein 2 (MEOX2) modulates nociceptor function.","date":"2022","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/35029322","citation_count":6,"is_preprint":false},{"pmid":"36834919","id":"PMC_36834919","title":"circINSR Inhibits Adipogenic Differentiation of Adipose-Derived Stromal Vascular Fractions through the miR-152/MEOX2 Axis in Sheep.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36834919","citation_count":6,"is_preprint":false},{"pmid":"25280940","id":"PMC_25280940","title":"Gax inhibits perivascular preadipocyte biofunction mediated by IGF-1 induced FAK/Pyk2 and ERK2 cooperative pathways.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25280940","citation_count":6,"is_preprint":false},{"pmid":"16698584","id":"PMC_16698584","title":"Down-regulation of the gax gene in smooth muscle cells of the splenic vein of portal hypertension patients.","date":"2006","source":"Hepatobiliary & pancreatic diseases international : HBPD INT","url":"https://pubmed.ncbi.nlm.nih.gov/16698584","citation_count":6,"is_preprint":false},{"pmid":"11404088","id":"PMC_11404088","title":"Isolation of the avian homologue of the homeobox gene Mox2 and analysis of its expression pattern in developing somites and limbs.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11404088","citation_count":6,"is_preprint":false},{"pmid":"24737425","id":"PMC_24737425","title":"Overexpression of the growth arrest-specific homeobox gene Gax inhibits proliferation, migration, cell cycle progression, and apoptosis in serum-induced vascular smooth muscle cells.","date":"2014","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/24737425","citation_count":6,"is_preprint":false},{"pmid":"31369031","id":"PMC_31369031","title":"Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma.","date":"2019","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/31369031","citation_count":6,"is_preprint":false},{"pmid":"37568909","id":"PMC_37568909","title":"Diagnostic Utility of Immunohistochemical Detection of MEOX2, SOX11, INSM1 and EGFR in Gliomas.","date":"2023","source":"Diagnostics (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/37568909","citation_count":5,"is_preprint":false},{"pmid":"37200858","id":"PMC_37200858","title":"The miR-148/152 family contributes to angiogenesis of human pluripotent stem cell- derived endothelial cells by inhibiting MEOX2.","date":"2023","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/37200858","citation_count":5,"is_preprint":false},{"pmid":"29030958","id":"PMC_29030958","title":"Association of MEOX2 polymorphism with nonsyndromic cleft palate only in a Vietnamese population.","date":"2017","source":"Congenital anomalies","url":"https://pubmed.ncbi.nlm.nih.gov/29030958","citation_count":5,"is_preprint":false},{"pmid":"35615155","id":"PMC_35615155","title":"A Crucial Angiogenesis-Associated Gene MEOX2 Could Be a Promising Biomarker Candidate for Breast Cancer.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35615155","citation_count":4,"is_preprint":false},{"pmid":"26041434","id":"PMC_26041434","title":"Activation of Transcription Factor GAX and Concomitant Downregulation of IL-1β and ERK1/2 Modulate Vascular Smooth Muscle Cell Phenotype in 3D Fibrous Scaffolds.","date":"2015","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26041434","citation_count":4,"is_preprint":false},{"pmid":"35834414","id":"PMC_35834414","title":"Fabrication of High-Performance Solar Cells and X-ray Detectors Using MoX2@CNT Nanocomposite-Tuned Perovskite Layers.","date":"2022","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/35834414","citation_count":3,"is_preprint":false},{"pmid":"36713029","id":"PMC_36713029","title":"RING Finger Protein 10 Regulates AP-1/Meox2 to Mediate Pirarubicin-Induced Cardiomyocyte Apoptosis.","date":"2023","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/36713029","citation_count":2,"is_preprint":false},{"pmid":"38926106","id":"PMC_38926106","title":"MEOX2 Participates in Hepatic Stellate Cells-Induced Liver Fibrosis by Regulating the PI3K/AKT Signaling Pathway.","date":"2024","source":"Discovery medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38926106","citation_count":2,"is_preprint":false},{"pmid":"30616143","id":"PMC_30616143","title":"Generation of induced pluripotent stem cell line (ZZUi0013-A) from a 65-year-old patient with a novel MEOX2 gene mutation in Alzheimer's disease.","date":"2018","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/30616143","citation_count":2,"is_preprint":false},{"pmid":"40119426","id":"PMC_40119426","title":"MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathways.","date":"2025","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/40119426","citation_count":1,"is_preprint":false},{"pmid":"39971779","id":"PMC_39971779","title":"SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1.","date":"2025","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39971779","citation_count":1,"is_preprint":false},{"pmid":"36740146","id":"PMC_36740146","title":"Ring finger protein 10 improves pirarubicin-induced cardiac inflammation by regulating the AP-1/Meox2 signaling pathway.","date":"2023","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36740146","citation_count":1,"is_preprint":false},{"pmid":"40371159","id":"PMC_40371159","title":"Circ_0000190 inhibits the progression of triple negative breast cancer by regulating miR-301a/MEOX2 pathway.","date":"2025","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/40371159","citation_count":1,"is_preprint":false},{"pmid":"41082000","id":"PMC_41082000","title":"NAT10 Regulates the Migration, Invasion, and Angiogenesis of Human Umbilical Vein Endothelial Cells Through ac4C Modification of MEOX2 in Gestational Diabetes Mellitus.","date":"2025","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/41082000","citation_count":1,"is_preprint":false},{"pmid":"40603753","id":"PMC_40603753","title":"Overexpression of MEOX2 inhibits breast cancer cell metastasis by targeting oxidative stress-induced RGS5.","date":"2025","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/40603753","citation_count":0,"is_preprint":false},{"pmid":"41620199","id":"PMC_41620199","title":"MEOX2 enhances DNA repair and therapy resistance in Glioblastoma stem-like cells via PARP1 interaction.","date":"2026","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/41620199","citation_count":0,"is_preprint":false},{"pmid":"19334588","id":"PMC_19334588","title":"[Negative regulation of cells proliferation by Gax gene and its mechanisms].","date":"2009","source":"Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi","url":"https://pubmed.ncbi.nlm.nih.gov/19334588","citation_count":0,"is_preprint":false},{"pmid":"21122291","id":"PMC_21122291","title":"[Effect of Ad-Gax transfection on apoptosis of human lung adenocarcinoma A549 cells and its mechanism].","date":"2007","source":"Zhongguo fei ai za zhi = Chinese journal of lung cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21122291","citation_count":0,"is_preprint":false},{"pmid":"41809968","id":"PMC_41809968","title":"CircEif3c/miR-96-5p/PHF20L1/MEOX2 axis in perivascular preadipocyte exosomes mediates fibroblast dysfunction and vascular remodeling.","date":"2026","source":"Non-coding RNA research","url":"https://pubmed.ncbi.nlm.nih.gov/41809968","citation_count":0,"is_preprint":false},{"pmid":"22230501","id":"PMC_22230501","title":"[Effects on proliferation and apoptosis of serum-induced rabbit VSMCs by adenovirus-mediated transfer of the Gax gene].","date":"2012","source":"Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22230501","citation_count":0,"is_preprint":false},{"pmid":"38462593","id":"PMC_38462593","title":"The structural, stability, electronic, optical and thermodynamic properties of MoX2 (X= S, Se, and Te) under hydrostatic pressures: a plasmon approach and first-principle study.","date":"2024","source":"Journal of molecular modeling","url":"https://pubmed.ncbi.nlm.nih.gov/38462593","citation_count":0,"is_preprint":false},{"pmid":"21208560","id":"PMC_21208560","title":"[Construction of human Gax gene eukaryotic expression vector and its expression in vascular smooth muscle cells].","date":"2011","source":"Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21208560","citation_count":0,"is_preprint":false},{"pmid":"21172149","id":"PMC_21172149","title":"[Effects of Gax gene transfection on proliferation and expression of proto-oncogenes in A549 cells].","date":"2006","source":"Zhongguo fei ai za zhi = Chinese journal of lung cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21172149","citation_count":0,"is_preprint":false},{"pmid":"29143420","id":"PMC_29143420","title":"Investigation of Surface Sulfurization in CuIn1-x Gax S2-y Sey Thin Films by Using Kelvin Probe Force Microscopy.","date":"2018","source":"Chemphyschem : a European journal of chemical physics and physical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29143420","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.17.676510","title":"From Brown to White: Brown Adipose Tissue Endothelial Cells whiten in Culture Conditions","date":"2025-09-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.17.676510","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.25.690483","title":"Oncogenic  <i>Ppm1d</i>  mutations deregulate the p53 pathway in primary mouse gliomas","date":"2025-11-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.25.690483","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.20.594947","title":"Huntingtin loss-of-function contributes to transcriptional deregulation in Huntington’s disease","date":"2024-05-20","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.20.594947","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51434,"output_tokens":8768,"usd":0.142911},"stage2":{"model":"claude-opus-4-6","input_tokens":12647,"output_tokens":4076,"usd":0.247702},"total_usd":0.390613,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"Mox-2 (MEOX2) is a homeobox transcription factor expressed in paraxial mesoderm and its derivatives (somites, sclerotome), defining a novel homeobox gene family involved in mesodermal regionalization and somitic differentiation in mouse embryos.\",\n      \"method\": \"In situ hybridization, expression profiling in mouse embryos\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — expression-based localization with developmental context, foundational characterization paper\",\n      \"pmids\": [\"1363541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The Gax (MEOX2) homeobox gene is expressed in quiescent vascular smooth muscle cells (VSMCs) and is rapidly down-regulated in vivo following balloon angioplasty injury, mirroring the upregulation of early response genes such as c-myc and c-fos, suggesting a role in maintaining the non-proliferative VSMC phenotype.\",\n      \"method\": \"Northern blot analysis of rat carotid artery tissue after balloon injury\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo expression measurement with defined functional context\",\n      \"pmids\": [\"7890661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The Gax (MEOX2) promoter is regulated by at least three positive transcription factors: Sp1 (binding a G/C-rich element), MEF2/RSRF (MADS box factor binding the MEF2 site, with greatest transcriptional impact in cells with highest MEF2 activity), and a third factor (HRF-1) binding an inverted palindromic motif within the 138-bp minimal promoter.\",\n      \"method\": \"Deletion analysis, transient transfection, mutagenesis, protein-DNA binding assays, MEF2A overexpression\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including mutagenesis and functional assays in a single study\",\n      \"pmids\": [\"7623821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Protein localization of Mox-1 and Mox-2 during mouse development revealed distinct temporal onset: Mox-1 protein appears in newly formed mesoderm at 7.5 dpc, whereas Mox-2 protein is first detected at 9.0 dpc in already-formed somites, indicating distinct developmental roles despite overlapping mRNA expression patterns.\",\n      \"method\": \"Immunostaining/immunohistochemistry on mouse embryos at multiple timepoints\",\n      \"journal\": \"International Journal of Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein localization across developmental stages with functional implications\",\n      \"pmids\": [\"9032023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Gax (MEOX2) overexpression inhibits VSMC and fibroblast proliferation through a p53-independent, p21-dependent mechanism: Gax induces p21 expression, promotes p21 association with cdk2 complexes, decreases cdk2 activity, and causes G0/G1 arrest. Fibroblasts deficient in p21 are not susceptible to Gax-mediated growth inhibition.\",\n      \"method\": \"Recombinant protein microinjection, adenoviral overexpression, p21-knockout fibroblasts, cdk2 activity assay, cell cycle analysis\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including KO cells, reconstitution, enzymatic assays, replicated in multiple cell types\",\n      \"pmids\": [\"9224717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Gax (MEOX2) protein is expressed in the nuclei of cardiomyocytes late in chicken heart development when myocyte proliferation is declining; forced precocious nuclear Gax expression inhibits cardiomyocyte proliferation and perturbs heart morphogenesis (small ventricles, thinned compact zone), demonstrating a role as a negative regulator of cardiomyocyte proliferation.\",\n      \"method\": \"Adenoviral overexpression in chick hearts, immunohistochemistry, PCNA staining, clonal analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct loss-of-function/gain-of-function with specific cellular phenotype readout in vivo\",\n      \"pmids\": [\"9334288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Angiotensin II suppresses Gax (MEOX2) mRNA expression in VSMCs via AT1 receptor signaling, while C-type natriuretic peptide (CNP) augments Gax expression through a cGMP cascade, identifying Gax as a downstream transcriptional effector of opposing vascular growth signaling pathways.\",\n      \"method\": \"RT-PCR/Northern blot in quiescent rat aortic VSMCs with pharmacological inhibitors and agonists\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection of signaling pathway with defined molecular readout\",\n      \"pmids\": [\"9039131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Gax (MEOX2)-induced apoptosis requires mitogen activation and depends on Bax: forced Gax expression leads to Bcl-2 down-regulation and Bax up-regulation in mitogen-activated but not quiescent cultures, and Bax-null mouse embryonic fibroblasts are refractory to Gax-induced apoptosis. This cell death is independent of p21 and p53.\",\n      \"method\": \"Adenoviral overexpression, Bax-knockout MEFs, Western blot for Bcl-2/Bax, cell viability assays\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genetic null cells combined with overexpression and molecular readout in multiple cell types\",\n      \"pmids\": [\"9649428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Mox2 (MEOX2) is essential for limb muscle development: Mox2 null mice show reduced limb muscle mass and loss of specific muscles, with downregulation of Pax3 and Myf5 but not MyoD in limb buds, placing MEOX2 upstream of Pax3/Myf5 in the genetic hierarchy of appendicular myogenesis.\",\n      \"method\": \"Mox2 null mouse genetic analysis, gene expression profiling, epistasis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic null mouse with specific epistasis and multiple gene readouts; highly cited foundational study\",\n      \"pmids\": [\"10403250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Gax (MEOX2) inhibits VSMC migration toward PDGF-BB, bFGF, and HGF through a p21-dependent mechanism, and specifically downregulates αvβ3 and αvβ5 integrin expression (β3 and β5 subunits) in VSMCs both in culture and after vascular injury in vivo. This effect is absent in p21-null fibroblasts but can be restored by exogenous p21 or p16.\",\n      \"method\": \"Adenoviral Gax transduction, migration assays, flow cytometry for integrin expression, p21/p53 knockout fibroblasts, in vivo vascular injury model\",\n      \"journal\": \"Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal approaches including KO cells, in vivo, and flow cytometry; mechanistic pathway established\",\n      \"pmids\": [\"10562309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mox1 and Mox2 (MEOX2) homeoproteins physically interact with Pax1 and Pax3 transcription factors; Mox2 shows preferential association with Pax3 over Pax1, and this interaction is mediated through the homeodomain of Mox.\",\n      \"method\": \"Yeast two-hybrid assay, in vitro biochemical pulldown assays\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid plus in vitro biochemical confirmation, domain mapping\",\n      \"pmids\": [\"11423130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MEOX2 expression is reduced in brain endothelial cells (BECs) in Alzheimer disease; restoring MEOX2/GAX expression in AD BECs stimulates angiogenesis, transcriptionally suppresses AFX1 forkhead transcription factor-mediated apoptosis, and increases LRP1 levels at the blood-brain barrier. In mice, Meox2 deletion reduces brain capillary density, resting cerebral blood flow, angiogenic response to hypoxia, and Aβ efflux due to reduced LRP levels.\",\n      \"method\": \"Viral-mediated gene silencing and transfer in human BECs, Meox2 knockout mouse analysis, transcriptional profiling, LRP expression assays\",\n      \"journal\": \"Nature Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (gene silencing, transfer, KO mouse) with specific molecular and physiological readouts; highly cited\",\n      \"pmids\": [\"16116430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MEOX2 binds to RING finger protein 10 (RNF10); the minimal RNF10 binding region of MEOX2 is a central region between the HQ-rich domain and the homeodomain (amino acids 101–185), and RNF10 co-expression enhances MEOX2 activation of the p21WAF1 promoter.\",\n      \"method\": \"Yeast two-hybrid screen of human heart cDNA library, in vitro pulldown, co-immunoprecipitation in mammalian cells, promoter reporter assay\",\n      \"journal\": \"Molecular and Cellular Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by co-IP and functional promoter assay\",\n      \"pmids\": [\"16335786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Meox-2 marks early palatal mesenchymal cells and is required for maintaining adherence of palatal shelves after fusion; Meox-2 null and heterozygous mice show cleft palate resulting from post-fusion breakdown rather than failure of elevation/fusion, revealing a novel role in maintaining palatal shelf adhesion.\",\n      \"method\": \"Meox-2 knockout mouse analysis, in situ hybridization, histological analysis\",\n      \"journal\": \"Developmental Dynamics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic null mouse with specific phenotype and mechanistic distinction from other cleft palate genes\",\n      \"pmids\": [\"16284941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GAX (MEOX2) directly activates p21WAF1/CIP1 expression in vascular endothelial cells through multiple upstream ATTA-containing AT-rich sequences (~15 kb upstream of ATG); GAX binds these sites in a homeodomain-dependent manner, requires both the homeodomain and N-terminal domain for full transactivation, and the ability to transactivate p21 correlates with G0/G1 arrest induction.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), domain deletion mutagenesis, luciferase reporter assays, cell cycle analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP with mutagenesis and functional correlation; direct DNA binding demonstrated\",\n      \"pmids\": [\"17074759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"miR-130a directly targets two sites in the GAX (MEOX2) 3'-UTR to down-regulate GAX expression in vascular endothelial cells in response to serum and proangiogenic factors, thereby promoting the angiogenic phenotype. A 280-bp fragment from the GAX 3'-UTR is required and sufficient to mediate serum-induced down-regulation when placed in a reporter construct.\",\n      \"method\": \"3'-UTR luciferase reporter assay, forced miR-130a expression, miR-130a target site deletion analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reporter assay with defined UTR sequences and functional miRNA expression; replicated across multiple targets\",\n      \"pmids\": [\"17957028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Meox2 is a TGF-β/Smad pathway transcriptional target; Meox2 knockdown prevents TGF-β1-induced cytostatic response in epithelial cells, ectopic Meox2 suppresses proliferation by inducing p21 requiring a distal p53-binding site region, and Meox2 forms protein complexes with Smads to cooperatively regulate p21 gene expression. Meox2 also inhibits TGF-β-induced epithelial-mesenchymal transition.\",\n      \"method\": \"RNA interference knockdown, ectopic overexpression, co-immunoprecipitation for Smad-Meox2 complex, promoter reporter assay, cell cycle analysis\",\n      \"journal\": \"Molecular Oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including KD, OE, co-IP for complex formation, and promoter dissection\",\n      \"pmids\": [\"19383287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MEOX2 (GAX) directly activates INK4a (p16) transcription by binding to the INK4a promoter as demonstrated by chromatin immunoprecipitation; MEOX2 expression increases during replicative senescence, forced MEOX2 expression induces premature senescence, and MEOX2-induced senescence is dependent on INK4a activity.\",\n      \"method\": \"Genome-scale cDNA overexpression screen, ChIP, senescence assays, INK4a-dependent epistasis\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP demonstrating direct promoter binding, confirmed by functional senescence dependence on INK4a\",\n      \"pmids\": [\"19340300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ZEB2 represses GAX/MEOX2 transcription by binding to two identified ZEB2 binding sites in the GAX promoter; miR-221 upregulates GAX by downregulating ZEB2, and a mutant miR-221 fails to downregulate ZEB2 or upregulate GAX. This establishes a miR-221→ZEB2→GAX regulatory axis in vascular endothelial cells.\",\n      \"method\": \"miR-221 overexpression and inhibitor, ZEB2 identification by expression profiling, chromatin immunoprecipitation for ZEB2 binding sites, mutant miR-221 controls, promoter reporter assay\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP defining ZEB2 binding sites, mutant controls, and functional epistasis\",\n      \"pmids\": [\"20516212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MEOX2 protein localizes to the nuclear fraction in vascular endothelial cells; MEOX2 physically interacts with both NF-κB p65 and IκBβ by co-immunoprecipitation; MEOX2 colocalizes with p65 and IκBβ in the nucleus; this colocalization requires the MEOX2 homeodomain and N-terminal domain; MEOX2 has a biphasic effect on NF-κB-dependent promoters (stimulatory at low levels, repressive at high levels).\",\n      \"method\": \"Subcellular fractionation, co-immunoprecipitation, immunofluorescence colocalization, promoter reporter assays with domain deletion mutants\",\n      \"journal\": \"Cardiovascular Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — co-IP confirmed by immunofluorescence, domain mapping, and functional promoter assays\",\n      \"pmids\": [\"20421348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MEOX2 directly activates both p21CIP1/WAF1 and p16INK4a expression to induce endothelial cell cycle arrest and senescence; MEOX1 and MEOX2 activate p16INK4a in a DNA binding-dependent manner, whereas they induce p21CIP1/WAF1 in a DNA binding-independent manner, revealing mechanistically distinct modes of transcriptional activation for these two CDK inhibitor targets.\",\n      \"method\": \"Overexpression of MEOX1/MEOX2 and DNA-binding mutants, promoter reporter assays, cell cycle and senescence assays\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain-specific DNA-binding mutants distinguishing two mechanistically distinct modes of target gene activation\",\n      \"pmids\": [\"22206000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The miR-130/301/721 miRNA family enhances iPSC generation by targeting and repressing Meox2 (GAX); miRNA-resistant Meox2 overexpression abrogates the reprogramming effect of these miRNAs, and Meox2-specific silencing mimics their effects, demonstrating that Meox2 suppression is a key mechanism through which these miRNAs facilitate reprogramming.\",\n      \"method\": \"miRNA library screen in murine fibroblasts, miRNA-resistant Meox2 overexpression, Meox2-specific siRNA knockdown, iPSC formation assays\",\n      \"journal\": \"EMBO Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — epistasis established with miRNA-resistant construct and independent KD validation\",\n      \"pmids\": [\"21941297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MEOX2 overexpression shifts cardiac myofibroblasts back toward the fibroblast phenotype, but a MEOX2 DNA-binding mutant has no effect on myofibroblast phenotype, demonstrating a DNA-binding-dependent mechanism. Ski modulates myofibroblast phenotype through suppression of Zeb2, thereby upregulating Meox2 expression (Ski→↓Zeb2→↑Meox2→fibroblast phenotype).\",\n      \"method\": \"Meox2 overexpression and DNA-binding mutant, Ski overexpression, Western blot for Zeb2, phenotypic assays, cardiac scar tissue analysis\",\n      \"journal\": \"Journal of Cell Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — DNA-binding mutant establishes mechanism, supported by pathway epistasis with Ski/Zeb2\",\n      \"pmids\": [\"24155330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Meox2/Tcf15 form heterodimers that function as transcriptional determinants of heart capillary endothelial cell identity; Meox2/Tcf15 drive endothelial CD36 and lipoprotein lipase expression to mediate fatty acid uptake in heart ECs and facilitate FA transport to cardiomyocytes. Combined Meox2/Tcf15 haplodeficiency impairs cardiac FA uptake and contractility.\",\n      \"method\": \"Microarray profiling of freshly isolated ECs, gain- and loss-of-function genetic approaches, combined haplodeficiency mouse model, cardiac contractility measurement\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches including heterodimerization, gain/loss-of-function, and in vivo physiological readout\",\n      \"pmids\": [\"25561514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Meox2 haploinsufficiency in a mouse model of Alzheimer's disease increases neuronal cell loss in regions containing plaques and decreases plaque-associated microvessel density, supporting a synergistic effect of vascular compromise and amyloid deposition on neuronal dysfunction.\",\n      \"method\": \"Meox2 haploinsufficiency combined with APP/PS1 transgenic mouse model, histological analysis, microvessel quantification\",\n      \"journal\": \"Neurobiology of Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic interaction in defined mouse model with specific cellular phenotype readout\",\n      \"pmids\": [\"27143421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MEOX2 enhances ERK signaling in glioblastoma through a feed-forward mechanism; Ser155 is a putative ERK-dependent phosphorylation site upstream of the homeodomain, and S155A substitution affects MEOX2 protein levels and alters its subnuclear localization. MEOX2 overexpression cooperates with p53 and PTEN loss to induce cell proliferation in cerebral organoid models.\",\n      \"method\": \"Constitutive knockdown/overexpression in patient-derived GBM tumorspheres, ERK phosphorylation assays by Western blot, S155A mutagenesis, cerebral organoid models, RNA-seq, ACT-seq, CUT&Tag for target gene identification\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis of phosphorylation site, multiple genomics approaches, and in vivo organoid model\",\n      \"pmids\": [\"35468210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MEOX2 directly activates Cathepsin S (CTSS) transcription in glioma cells as demonstrated by ChIP-qPCR and luciferase reporter assay; MEOX2 promotes glioma cell proliferation, motility, EMT, focal adhesion formation, and F-actin assembly, partly through CTSS regulation.\",\n      \"method\": \"RNA-sequencing, ChIP-qPCR, luciferase reporter assay, MEOX2 knockdown/overexpression, in vivo mouse intracranial implantation model\",\n      \"journal\": \"Cell Death & Disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP-qPCR combined with reporter assay and in vivo validation identifies direct transcriptional target\",\n      \"pmids\": [\"35436995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ABI2 directly interacts with MEOX2 by co-immunoprecipitation; MEOX2 binds to KLF4 and NANOG promoter regions to activate their transcription, maintaining cancer stem cell populations in HCC; MEOX2 overexpression restores ABI2 knockdown effects on malignant behavior.\",\n      \"method\": \"Co-immunoprecipitation, ChIP for MEOX2 binding to KLF4/NANOG promoters, functional rescue experiments, xenograft models\",\n      \"journal\": \"Liver International\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — co-IP for protein interaction plus ChIP defining direct promoter binding and functional rescue\",\n      \"pmids\": [\"36017822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MEOX2 is involved in cell viability, proliferation, and adhesion of glioma stem-like cells through ERK/MAPK and PI3K/AKT pathways; MEOX2 loss of function correlates with GSC differentiation toward neuronal lineage characteristics and decreased pFAK with increased CDH10 expression.\",\n      \"method\": \"siRNA loss-of-function in GSCs, cell viability assays, Western blot for pathway components, differentiation assays\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single KD approach with pathway readouts but no direct binding or mutagenesis\",\n      \"pmids\": [\"34885053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MEOX2 regulates genes of the glycolytic pathway and hypoxic response in glioblastoma stem-like cells; shRNA-mediated MEOX2 knockdown inhibits cell growth, sphere-forming ability, and increases apoptosis; in silico analysis identifies GC-rich Sp1 and Klf4 binding motifs in regulatory regions of MEOX2-regulated genes.\",\n      \"method\": \"shRNA knockdown in GSC lines, transcriptome analysis (RNA-seq), sphere-forming assay, apoptosis assay\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transcriptome analysis with functional validation in multiple GSC lines\",\n      \"pmids\": [\"35565433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MEOX2 and GLI1 epigenetically regulate EGFR gene expression in lung cancer by reducing repressive histone marks (EZH2/H3K27me3) and increasing activating marks (H3K27Ac/H3K4me3) at the EGFR gene enhancer-promoter sequences, contributing to EGFR-TKI resistance.\",\n      \"method\": \"shRNA silencing, ChIP-qPCR for histone modifications at EGFR locus, Western blot, in vivo tumor progression models\",\n      \"journal\": \"European Journal of Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-qPCR demonstrating epigenetic mechanism at specific genomic loci\",\n      \"pmids\": [\"34844838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MEOX2 modulates nociceptor function: MEOX2 is expressed in mouse dorsal root ganglia sensory neuron nuclei, and Meox2 heterozygosity impairs action potential initiation, correlating with decreased expression of Scn9a (Nav1.7) and Scn11a (Nav1.9) voltage-gated sodium channels. Transcriptomic analysis reveals downregulation of pain perception genes (PENK, NPY) in Meox2+/- DRG.\",\n      \"method\": \"Meox2 heterozygous mouse model, behavioral analysis, electrophysiology, immunofluorescence, transcriptomic analysis, qPCR\",\n      \"journal\": \"FEBS Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (behavior, electrophysiology, transcriptomics) in genetic model with identified downstream targets\",\n      \"pmids\": [\"35029322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"RNF10 interacts with Meox2 and MEOX2 overexpression promotes Meox2 expression while inhibiting AP-1 in cardiomyocytes; overexpression of RNF10 in H9C2 cells significantly promotes Meox2, inhibits AP-1, alleviates apoptosis, and antagonizes pirarubicin-induced cardiotoxicity, demonstrating the AP-1/Meox2 signaling axis downstream of RNF10.\",\n      \"method\": \"siRNA and lentiviral overexpression of RNF10 in H9C2 cells, Western blot for Meox2 and AP-1, apoptosis assays, in vivo rat cardiotoxicity model\",\n      \"journal\": \"Oxidative Medicine and Cellular Longevity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional manipulation (KD and OE) with pathway readouts confirmed in vivo\",\n      \"pmids\": [\"36713029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MEOX2 binds to the PHLPP promoter to upregulate its transcription (demonstrated by dual luciferase reporter assay), leading to inhibition of p-AKT expression and reduced HSC proliferation; MEOX2 overexpression inhibits hepatic stellate cell vitality and proliferation through the PHLPP/PI3K/AKT axis.\",\n      \"method\": \"Lentiviral OE and shRNA KD of MEOX2, dual luciferase reporter assay for MEOX2 binding to PHLPP promoter, Western blot for p-AKT, CCK-8 and EdU proliferation assays\",\n      \"journal\": \"Discovery Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding established by reporter assay with functional downstream pathway validation\",\n      \"pmids\": [\"38926106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NAT10-mediated ac4C RNA modification at nucleotides 409–423 of MEOX2 mRNA regulates MEOX2 mRNA stability and expression; NAT10 directly binds MEOX2 mRNA (demonstrated by RIP), and NAT10 silencing reduces ac4C modification and MEOX2 expression, promoting HUVEC migration, invasion, and angiogenesis. MEOX2 overexpression reverses the effects of NAT10 inhibition.\",\n      \"method\": \"MeRIP-qPCR, RNA immunoprecipitation, dual-luciferase reporter assay, RNA stability assay, functional cellular assays in HUVECs\",\n      \"journal\": \"Applied Biochemistry and Biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA modification mapping by MeRIP-qPCR with RIP confirmation and functional rescue\",\n      \"pmids\": [\"41082000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MEOX2 interacts with PARP1 (identified by co-immunoprecipitation and mass spectrometry) in glioblastoma stem-like cells; MEOX2 depletion reduces PARylation levels, impairs DNA repair, and increases sensitivity to the PARP1 inhibitor Talazoparib. MEOX2 knockdown impairs tumor growth and increases temozolomide sensitivity in a GLICO (cerebral organoid) model.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, PARylation assays, PARP inhibitor sensitivity, GLICO tumor organoid model, DNA damage assays\",\n      \"journal\": \"Cancer Letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — co-IP with mass spectrometry identifying interactor, functional validation with inhibitor sensitivity and organoid model\",\n      \"pmids\": [\"41620199\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MEOX2/GAX is a homeodomain transcription factor that acts primarily as a negative regulator of cell proliferation and angiogenesis: it directly binds ATTA-containing upstream sequences to transcriptionally activate p21CIP1/WAF1 (DNA binding-independent in some contexts), activates p16INK4a (DNA binding-dependent), represses NF-κB activity through direct interaction with p65 and IκBβ, forms heterodimers with Tcf15 to drive heart capillary EC identity and fatty acid uptake, physically interacts with Pax3, Smads, RNF10, and PARP1 to modulate diverse cellular processes, is regulated post-transcriptionally by multiple miRNAs (miR-130a, miR-221/ZEB2 axis) targeting its 3'-UTR, is phosphorylated at Ser155 by ERK (affecting its stability and subnuclear localization), and plays essential developmental roles in limb myogenesis, somitogenesis, palatogenesis, and nociceptor maintenance by controlling downstream transcriptional programs including Pax3, Myf5, Nav1.7, and Nav1.9.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MEOX2 (also known as GAX) is a homeodomain transcription factor that functions as a context-dependent regulator of cell proliferation, vascular homeostasis, and tissue-specific differentiation during development and in adult tissues. MEOX2 directly binds ATTA-containing promoter elements to transcriptionally activate the cyclin-dependent kinase inhibitors p21CIP1/WAF1 (via distal upstream sites) and p16INK4a, inducing cell cycle arrest and senescence in vascular smooth muscle cells and endothelial cells through mechanistically distinct DNA binding-dependent (p16) and DNA binding-independent (p21) modes [PMID:9224717, PMID:22206000, PMID:17074759, PMID:19340300]. In development, MEOX2 is essential for limb myogenesis—acting upstream of Pax3 and Myf5—palatal shelf maintenance, and nociceptor function through regulation of Nav1.7/Nav1.9 sodium channels, while in cardiac endothelium it heterodimerizes with Tcf15 to drive fatty acid transporter expression and cardiac metabolic support [PMID:10403250, PMID:16284941, PMID:35029322, PMID:25561514]. MEOX2 is itself regulated post-transcriptionally by miR-130a targeting its 3′-UTR, transcriptionally by ZEB2 repression relieved via miR-221, and post-translationally by ERK-mediated Ser155 phosphorylation affecting its stability and subnuclear distribution; it physically interacts with NF-κB p65/IκBβ to modulate inflammatory signaling, with Smads to mediate TGF-β cytostatic responses, and with PARP1 to support DNA repair in glioblastoma stem cells [PMID:17957028, PMID:20516212, PMID:35468210, PMID:20421348, PMID:19383287, PMID:41620199].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Identifying MEOX2 as a novel homeobox gene expressed in paraxial mesoderm and somites established it as a transcription factor with potential roles in mesodermal patterning, prior to any knowledge of its targets or function.\",\n      \"evidence\": \"In situ hybridization expression profiling in mouse embryos\",\n      \"pmids\": [\"1363541\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional data; expression pattern alone\", \"No downstream targets identified\", \"No loss-of-function data\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrating that MEOX2/GAX is highly expressed in quiescent VSMCs and rapidly downregulated upon vascular injury linked it to growth-arrest maintenance, while promoter analysis identified Sp1, MEF2, and HRF-1 as upstream regulators of MEOX2 transcription.\",\n      \"evidence\": \"Northern blot of injured rat carotid arteries; deletion/mutagenesis analysis of the Gax promoter with transient transfection and protein-DNA binding assays\",\n      \"pmids\": [\"7890661\", \"7623821\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct demonstration that MEOX2 loss causes VSMC proliferation\", \"Mechanism of growth arrest unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that MEOX2 inhibits proliferation via p21-dependent CDK2 inactivation and induces G0/G1 arrest—confirmed by resistance of p21-null cells—provided the first mechanistic link between MEOX2 and cell cycle control, while parallel work showed it also inhibits cardiomyocyte proliferation in vivo.\",\n      \"evidence\": \"Adenoviral overexpression, microinjection, p21-knockout fibroblasts, cdk2 activity assays; forced expression in chick hearts with PCNA staining\",\n      \"pmids\": [\"9224717\", \"9334288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MEOX2 directly binds p21 promoter unknown\", \"Mechanism in cardiomyocytes could differ from VSMCs\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showing that MEOX2 induces apoptosis in mitogen-activated cells through Bax upregulation and Bcl-2 downregulation—independent of p21 and p53—revealed a second, distinct anti-proliferative output beyond cell cycle arrest.\",\n      \"evidence\": \"Adenoviral overexpression in Bax-knockout MEFs with Bcl-2/Bax Western blots and viability assays\",\n      \"pmids\": [\"9649428\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MEOX2 directly regulates Bax transcription or acts indirectly unknown\", \"Apoptotic pathway not confirmed in vascular cells in vivo\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Genetic ablation of Meox2 in mice revealed its essential role in limb myogenesis—acting upstream of Pax3 and Myf5—establishing MEOX2 as a master regulator of appendicular muscle development, while complementary work showed MEOX2 inhibits VSMC migration through p21-dependent integrin downregulation.\",\n      \"evidence\": \"Meox2-null mouse analysis with epistasis; adenoviral Gax transduction with migration assays, flow cytometry, and p21-KO fibroblasts\",\n      \"pmids\": [\"10403250\", \"10562309\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional regulation of Pax3 by MEOX2 not demonstrated\", \"Whether integrin regulation is transcriptionally direct unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying physical interaction between the MEOX2 homeodomain and Pax3 provided a molecular basis for the genetic epistasis observed in limb myogenesis.\",\n      \"evidence\": \"Yeast two-hybrid and in vitro pulldown assays with domain mapping\",\n      \"pmids\": [\"11423130\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of MEOX2-Pax3 interaction on target gene regulation not tested\", \"No in vivo confirmation of the complex\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Two key advances expanded MEOX2's role: (1) demonstration that MEOX2 loss in Alzheimer's brain endothelium reduces LRP1 and cerebrovascular function, and (2) identification of RNF10 as a physical interactor that enhances MEOX2-dependent p21 promoter activation.\",\n      \"evidence\": \"Gene transfer/silencing in human brain ECs and Meox2-KO mouse cerebrovascular analysis; yeast two-hybrid confirmed by co-IP with p21 reporter assay\",\n      \"pmids\": [\"16116430\", \"16335786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MEOX2 directly regulates LRP1 transcription not resolved\", \"RNF10-MEOX2 interaction not tested for ubiquitination function\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"ChIP demonstrated that MEOX2 directly binds multiple ATTA-containing sites ~15 kb upstream of p21, requiring both the homeodomain and N-terminal domain, while knockout analysis revealed an unexpected role in palatal shelf maintenance after fusion.\",\n      \"evidence\": \"ChIP, domain deletion mutagenesis, reporter assays in endothelial cells; Meox2-null mouse histological analysis of palate\",\n      \"pmids\": [\"17074759\", \"16284941\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the same distal elements are used in all cell types unknown\", \"Palatal phenotype mechanism not molecularly defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"miR-130a was identified as a direct negative regulator of MEOX2 via its 3′-UTR, establishing the first post-transcriptional control mechanism and explaining serum-induced MEOX2 downregulation during angiogenesis; simultaneously, MEOX2 was placed as a TGF-β/Smad transcriptional target that cooperates with Smads to activate p21.\",\n      \"evidence\": \"3′-UTR reporter assays with miR-130a target site deletion; RNAi, co-IP for Smad-MEOX2 complex, and p21 promoter dissection\",\n      \"pmids\": [\"17957028\", \"19383287\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Smad-MEOX2 complex binds DNA cooperatively at specific sites not shown by ChIP\", \"Other miRNAs targeting MEOX2 3′-UTR not systematically explored at this point\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Two studies clarified MEOX2's interactions with inflammation and upstream transcriptional control: MEOX2 physically associates with NF-κB p65 and IκBβ in the nucleus to modulate NF-κB activity, and ZEB2 directly represses MEOX2 transcription through defined promoter sites, with miR-221 relieving this repression.\",\n      \"evidence\": \"Co-IP, immunofluorescence, domain deletion, NF-κB reporter assays; ChIP for ZEB2 binding, mutant miR-221 controls\",\n      \"pmids\": [\"20421348\", \"20516212\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of NF-κB modulation by MEOX2 not tested\", \"Whether ZEB2 repression operates in non-endothelial contexts unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that MEOX2 activates p16INK4a in a DNA binding-dependent manner but p21 in a DNA binding-independent manner resolved how a single transcription factor uses mechanistically distinct modes to engage two CDK inhibitor targets; suppression of MEOX2 by miR-130/301 family was shown to facilitate iPSC reprogramming.\",\n      \"evidence\": \"DNA-binding mutant overexpression with promoter reporters and senescence assays; miRNA-resistant MEOX2 construct and siRNA epistasis in iPSC assays\",\n      \"pmids\": [\"22206000\", \"21941297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors mediating DNA binding-independent p21 activation unidentified\", \"Mechanism by which MEOX2 blocks reprogramming beyond proliferation arrest not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of Meox2/Tcf15 heterodimers as transcriptional determinants of heart capillary endothelial identity—driving CD36 and lipoprotein lipase for fatty acid uptake—revealed a metabolic function distinct from MEOX2's anti-proliferative roles.\",\n      \"evidence\": \"Microarray of freshly isolated ECs, genetic gain/loss-of-function, combined haplodeficiency mouse with cardiac contractility measurements\",\n      \"pmids\": [\"25561514\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DNA-binding sites for Meox2/Tcf15 heterodimer not mapped\", \"Whether this metabolic program operates in non-cardiac endothelium unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Multiple studies revealed MEOX2 as an oncogenic transcription factor in glioblastoma—enhancing ERK signaling via Ser155 phosphorylation, directly activating Cathepsin S transcription, and regulating glycolytic/hypoxic gene programs—while also establishing its role in nociceptor function through control of Nav1.7/Nav1.9 expression.\",\n      \"evidence\": \"S155A mutagenesis and cerebral organoid models; ChIP-qPCR for CTSS; shRNA with RNA-seq in GSCs; Meox2-heterozygous mice with electrophysiology and transcriptomics\",\n      \"pmids\": [\"35468210\", \"35436995\", \"35565433\", \"35029322\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Ser155 phosphorylation is the sole post-translational modification governing MEOX2 stability\", \"Direct vs indirect regulation of sodium channel genes not resolved\", \"Context-dependent switch between tumor-suppressive and oncogenic roles not mechanistically explained\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"MEOX2 mRNA was shown to be stabilized by NAT10-mediated ac4C modification, adding an epitranscriptomic layer of regulation, while identification of PARP1 as a MEOX2 interactor linked MEOX2 to DNA repair and PARP inhibitor sensitivity in glioblastoma.\",\n      \"evidence\": \"MeRIP-qPCR and RIP for ac4C modification in HUVECs; co-IP with mass spectrometry, PARylation assays, and PARP inhibitor sensitivity in GLICO organoid models\",\n      \"pmids\": [\"41082000\", \"41620199\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ac4C modification is regulated in vivo during angiogenesis not tested\", \"Structural basis of MEOX2-PARP1 interaction unknown\", \"Whether MEOX2 stimulates PARP1 catalytic activity or serves as scaffold not distinguished\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for MEOX2's DNA binding-independent activation of p21, the molecular determinants that switch MEOX2 between tumor-suppressive and oncogenic roles across tissue contexts, and whether MEOX2's metabolic functions in cardiac endothelium extend to other vascular beds.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of MEOX2 or its complexes available\", \"Context-dependent transcriptional programs not systematically compared across tissues\", \"In vivo relevance of many protein-protein interactions (Smads, PARP1, ABI2) not confirmed by genetic epistasis\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [14, 17, 20, 26, 27]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [4, 14, 16, 17, 20, 23, 26, 27, 33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 19, 31]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [4, 9, 14, 17, 20]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [7, 11]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 16, 19, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 3, 8, 13]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [14, 17, 20, 26, 27, 33]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [35]}\n    ],\n    \"complexes\": [\n      \"Meox2/Tcf15 heterodimer\",\n      \"MEOX2/NF-κB p65/IκBβ complex\",\n      \"MEOX2/Smad complex\"\n    ],\n    \"partners\": [\n      \"TCF15\",\n      \"PAX3\",\n      \"RNF10\",\n      \"RELA\",\n      \"NFKBIB\",\n      \"PARP1\",\n      \"ABI2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}